Protara Therapeutics, Inc.
TARA
$5.42
$0.163.04%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -17.31M | -13.26M | -14.96M | -11.91M | -12.77M |
| Total Depreciation and Amortization | 93.00K | 88.00K | 98.00K | 83.00K | 82.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 995.00K | 924.00K | 804.00K | 930.00K | 884.00K |
| Change in Net Operating Assets | -731.00K | -206.00K | 1.81M | -3.81M | 2.50M |
| Cash from Operations | -16.95M | -12.45M | -12.25M | -14.71M | -9.31M |
| Capital Expenditure | -24.00K | -4.00K | -22.00K | -44.00K | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -26.88M | -6.50M | -47.70M | -58.31M | 22.50M |
| Cash from Investing | -26.91M | -6.51M | -47.72M | -58.35M | 22.50M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 81.18M | -- | 222.00K | 2.53M | 103.90M |
| Repurchase of Common Stock | 0.00 | -201.00K | 0.00 | -185.00K | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -214.00K | 214.00K | -214.00K | -614.00K | -6.05M |
| Cash from Financing | 80.96M | 13.00K | 8.00K | 1.73M | 97.85M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 37.11M | -18.95M | -59.97M | -71.34M | 111.04M |